Literature DB >> 8417824

Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.

A Iavarone1, A Lasorella, T Servidei, R Riccardi, R Mastrangelo.   

Abstract

The mechanisms of the uptake and release of m-iodobenzylguanidine (MIGB) have been studied in 5 neuroblastoma (NB) cell lines and in 4 clonal NB sublines with a homogeneous phenotype. A specific uptake system for MIBG was found in 8 of 9 NB cell lines or subpopulations. The uptake was characterized by temperature dependency, high affinity, saturability, sodium dependency, and imipramine sensitivity. The majority of NB cell lines that possessed a specific uptake system for MIBG were also able to efficiently store the incorporated drug. However, 3 NB cell lines were identified without the ability to retain high levels of MIBG, despite the presence of a specific uptake system. We also report that a clonal subline, SH-EP1, which has a nonneuroblastic phenotype, failed both MIBG uptake and retention. Conversely, the parental cell line, SK-N-SH, and the neuroblastic subline SH-SY5Y possessed both a specific uptake system and the ability to store MIBG. In addition, the induction of neuronal differentiation with retinoic acid increased the velocity of uptake and the storage efficiency for MIBG in the clonal subline SH-SY5Y. We conclude that MIBG uptake and storage should be considered to be frequent but independent neuronal functions of human NB cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417824

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  A human neuroblastoma xenograft model for 125-I-metaiodobenzylguanidine biodistribution studies.

Authors:  M Lavitrano; T Servidei; S Mastrangelo; A Tornesello; D Fioretti; C Di Stefano; A Riccardi; R Franceschini; R Riccardi
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.

Authors:  Yanlin Zhao; Xiao Zhong; Xiaohong Ou; Huawei Cai; Xiaoai Wu; Rui Huang
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 3.  Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

Authors:  A R Wafelman; C A Hoefnagel; R A Maes; J H Beijnen
Journal:  Eur J Nucl Med       Date:  1994-06

4.  Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.

Authors:  Jennifer E Gains; Neil J Sebire; Veronica Moroz; Keith Wheatley; Mark N Gaze
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-17       Impact factor: 9.236

5.  Medulloblastoma with extensive nodularity: single photon emission CT study with iodine-123 metaiodobenzylguanidine.

Authors:  Yuichiro Naitoh; Toshio Sasajima; Hiroyuki Kinouchi; Shigeki Mikawa; Kazuo Mizoi
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

6.  Development of serotonin transporter reuptake inhibition assays using JAR cells.

Authors:  Ann M Decker; Bruce E Blough
Journal:  J Pharmacol Toxicol Methods       Date:  2018-03-16       Impact factor: 1.950

Review 7.  Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.

Authors:  Steven G DuBois; Katherine K Matthay
Journal:  Nucl Med Biol       Date:  2008-08       Impact factor: 2.408

8.  Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.

Authors:  D K Strickland; G Vaidyanathan; H S Friedman; M R Zalutsky
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  Local delivery of (131)I-MIBG to treat peritoneal neuroblastoma.

Authors:  Seigo Kinuya; Xiao-Feng Li; Kunihiko Yokoyama; Hirofumi Mori; Kazuhiro Shiba; Naoto Watanabe; Noriyuki Shuke; Hisashi Bunko; Takatoshi Michigishi; Norihisa Tonami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-17       Impact factor: 9.236

Review 10.  Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.

Authors:  Keri A Streby; Nilay Shah; Mark A Ranalli; Anne Kunkler; Timothy P Cripe
Journal:  Pediatr Blood Cancer       Date:  2014-08-30       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.